Paul Desmond

IDDF2021-ABS-0056 Liver stiffness plus platelets predicts long-term outcomes in child-pugh a cirrhosis

Tanya Lee, Elliot Freeman, Daniel Clayton-Chub, Stuart Roberts, Nik Ding, William Kemp, Rohit Sawhney, John Lubel, David Iser, Jessica Howell, Catherine Croagh, Thai Hong, Barbara Demediuk, Paul Desmond, Swee Lin Chen Yi Mei, Alexander Thompson, Jacinta Holmes

Conference Proceedings  |  2021  |  Clinical Hepatology

Not all low grade dysplasia in Barrett's oesophagus is the same: using specific histological criteria in predicting progression to neoplasia.

Edward H Tsoi, Richard A Williams, Michael Christie, David Machet, Siddhartha Deb, Vijaya Sundararajan, Georgina R Cameron, Paul V Desmond, Andrew CF Taylor

Journal article  |  2021  |  Pathology

Barrett's oesophagus with low grade dysplasia (LGD) is a risk factor for progression to high grade dysplasia (HGD) and oesophageal..

Evaluation of Endoscopic Practices and Outcomes in Follow-up of Gastric Ulcers.

Linda S Yang, Imogen Hartley, Alexander J Thompson, Paul Desmond, Andrew CF Taylor, Alan Moss, Bronte A Holt

Journal article  |  2021  |  J Clin Gastroenterol

GOAL: The aim of this study was to evaluate current practice in gastric ulcer follow-up to establish diagnostic yield and predicto..

Endoscopic features of buried Barrett's mucosa

Linda S Yang, Bronte A Holt, Richard Williams, Richard Norris, Edward Tsoi, Georgina Cameron, Paul Desmond, Andrew CF Taylor

Journal article  |  2021  |  GASTROINTESTINAL ENDOSCOPY

BACKGROUND AND AIMS: Buried Barrett's mucosa is defined as intestinal metaplasia that is "buried" under the normal-appearing squam..

Quantifying early gastric cancer in Australia: What is the opportunity for gastric endoscopic submucosal dissection?

Linda S Yang, Andrew CF Taylor, Alexander J Thompson, Paul Desmond, Bronte A Holt

Conference Proceedings  |  2021  |  JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

BACKGROUND AND AIMS: Endoscopic submucosal dissection (ESD) is the recommended treatment for early gastric cancer (EGC). However, ..

Barrett's esophagus with low-grade dysplasia: high rate of upstaging at Barrett's esophagus referral units suggests progression rates may be overestimated.

Edward H Tsoi, Puneet Mahindra, Georgina Cameron, Richard Williams, Richard Norris, Paul V Desmond, Spiro Raftopoulos, Darren Pavey, Arti Rattan, Luke F Hourigan, Richard Lee, Michael J Bourke, Naaz Sidhu, Rajvinder Singh, Andrew Chan, Sudarshan Krishnamurthi, Andrew CF Taylor

Journal article  |  2021  |  Gastrointest Endosc

BACKGROUND AND AIMS: The reported progression rate from low-grade dysplasia (LGD) in Barrett's esophagus (BE) to high-grade dyspla..

A qualitative exploration of enablers for hepatitis B clinical management among ethnic Chinese in Australia

Yinzong Xiao, Jack Wallace, Alex Thompson, Margaret Hellard, Caroline van Gemert, Jacinta A Holmes, Catherine Croagh, Jacqui Richmond, Tim Papaluca, Samuel Hall, Thai Hong, Barbara Demediuk, David Iser, Marno Ryan, Paul Desmond, Kumar Visvanathan, Jess Howell

Journal article  |  2021  |  JOURNAL OF VIRAL HEPATITIS

An estimated 18% of people living with chronic hepatitis B (CHB) in Australia were born in China. While guideline-based care, incl..

Non-invasive fibrosis algorithms are clinically useful for excluding cirrhosis in prisoners living with hepatitis C

Timothy Papaluca, Anne Craigie, Lucy McDonald, Amy Edwards, Michael MacIsaac, Jacinta A Holmes, Matthew Jarman, Tanya Lee, Hannah Huang, Andrew Chan, Mark Lai, Vijaya Sundararajan, Joseph S Doyle, Margaret Hellard, Mark Stoove, Jessica Howell, Paul Desmond, David Iser, Alexander J Thompson

Journal article  |  2020  |  PLOS ONE

BACKGROUND AND AIMS: Prison-based HCV treatment rates remain low due to multiple barriers, including accessing transient elastogra..

Addressing pregnancy-related concerns in women with inflammatory bowel disease: Insights from the patient's perspective

Emma K Flanagan, Jacqui Richmond, Alexander J Thompson, Paul Desmond, Sally J Bell

Journal article  |  2020  |  JGH OPEN

Background and Aim: Therapeutic options for inflammatory bowel disease (IBD) have expanded, as has the use of IBD medications in w..

HBV-STOP study: Large hepatitis B virus flares off nucleot(s)ide analog therapy cause large innate immune response

S Hall, G Burns, D Anagnostou, R Morris, B Mooney, M Levy, W Sievert, J Lubel, A Nicoll, S Strasser, P Desmond, M Ngu, P Angus, C Meredith, P Revill, K Jackson, S Bowden, S Locarnini, A Thompson, K Visvanathan

Conference Proceedings  |  2020  |  JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY